You have 9 free searches left this month | for more free features.

Pimavanserin

Showing 26 - 40 of 40

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Schizophrenia Trial in Worldwide (Pimavanserin, Placebo)

Completed
  • Schizophrenia
  • Pimavanserin
  • Placebo
  • Phoenix, Arizona
  • +105 more
May 29, 2020

Adjunctive Treatment of MDD Trial in Worldwide (Pimavanserin, Placebo)

Completed
  • Adjunctive Treatment of Major Depressive Disorder
  • Pimavanserin
  • Placebo
  • Helsinki, Finland
  • +43 more
Jun 25, 2020

Adjunctive Treatment of MDD Trial in United States (Pimavanserin, Placebo)

Completed
  • Adjunctive Treatment of Major Depressive Disorder
  • Pimavanserin
  • Placebo
  • Birmingham, Alabama
  • +35 more
Oct 25, 2019

Agitation and Aggression in Alzheimer's Disease Trial in Worldwide (Pimavanserin 34 mg, Pimavanserin 20 mg, Placebo)

Terminated
  • Agitation and Aggression in Alzheimer's Disease
  • Pimavanserin 34 mg
  • +2 more
  • Costa Mesa, California
  • +55 more
Mar 7, 2019

Dementia Trial in Exeter (COVID WHELD)

Recruiting
  • Dementia
  • COVID WHELD
  • Exeter, Devon, UK, United Kingdom
    University of Exeter
May 25, 2021

Parkinson's Disease Psychosis Trial in Worldwide (Pimavanserin tartrate (ACP-103))

Completed
  • Parkinson's Disease Psychosis
  • Pimavanserin tartrate (ACP-103)
  • Gilbert, Arizona
  • +134 more
May 29, 2019

Parkinson Disease Psychosis Trial in London (Saracatinib, Placebo Oral Tablet)

Unknown status
  • Parkinson Disease Psychosis
  • London, Camberwell, United Kingdom
    Mitul Mehta
Aug 12, 2019

Alzheimer's Disease Psychosis Trial in London (Pimavanserin tartrate, Placebo)

Completed
  • Alzheimer's Disease Psychosis
  • Pimavanserin tartrate
  • Placebo
  • London, United Kingdom
    (unnamed)
Sep 28, 2017

Parkinson's Disease Psychosis Trial (Pimavanserin tartrate)

Approved for marketing
  • Parkinson's Disease Psychosis
  • Pimavanserin tartrate
  • (no location specified)
Apr 17, 2017

Parkinson's Disease Psychosis Trial in Worldwide (Pimavanserin tartrate (ACP-103))

Completed
  • Parkinson's Disease Psychosis
  • Pimavanserin tartrate (ACP-103)
  • La Habra, California
  • +49 more
Apr 18, 2017

Parkinson's Disease Psychosis Trial in Worldwide (Pimavanserin tartrate (ACP-103), Placebo)

Completed
  • Parkinson's Disease Psychosis
  • Pimavanserin tartrate (ACP-103)
  • Placebo
  • Gilbert, Arizona
  • +77 more
Apr 18, 2017

Parkinson's Disease, Dyskinesias Trial run by the NINDS (Intravenous Levodopa, ACP-103)

Completed
  • Parkinson's Disease
  • Dyskinesias
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017

Parkinson's Disease Psychosis Trial in Canada, United States (pimavanserin tartrate, )

Completed
  • Parkinson's Disease Psychosis
  • pimavanserin tartrate
  • placebo
  • Gilbert, Arizona
  • +62 more
Feb 6, 2014

Schizophrenia Trial in Brazil, United States (ACP-103)

Completed
  • Schizophrenia
  • Cerritos, California
  • +16 more
Mar 20, 2007

Hallucinations, Psychoses, Parkinson's Disease Trial in United States (ACP-103)

Completed
  • Hallucinations
  • +2 more
  • Fountain Valley, California
  • +12 more
Dec 5, 2005